Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Clinical Trial of Atezolizumab plus Chemotherapy, Trastuzumab and Pertuzumab for Patients with HER2-Positive Breast Cancer (IMpassion050)

    A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer

    • Cancer
    • Breast Cancer
    • HER2-Positive Breast Cancer

    For the latest version of this information please go to www.forpatients.roche.com